RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 37.159
EU - Europa 17.524
AS - Asia 14.997
SA - Sud America 2.103
Continente sconosciuto - Info sul continente non disponibili 436
AF - Africa 363
OC - Oceania 52
Totale 72.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.457
GB - Regno Unito 5.030
IT - Italia 4.648
SG - Singapore 4.146
CN - Cina 4.127
SE - Svezia 3.138
HK - Hong Kong 1.864
BR - Brasile 1.603
VN - Vietnam 1.530
DE - Germania 956
BD - Bangladesh 704
UA - Ucraina 655
TR - Turchia 651
RU - Federazione Russa 639
FI - Finlandia 606
FR - Francia 569
KR - Corea 491
IN - India 381
CA - Canada 346
BG - Bulgaria 247
NL - Olanda 195
ID - Indonesia 174
AR - Argentina 156
MX - Messico 141
IQ - Iraq 136
JP - Giappone 127
IE - Irlanda 121
ZA - Sudafrica 112
ES - Italia 109
RO - Romania 91
PK - Pakistan 90
BE - Belgio 87
PL - Polonia 84
EC - Ecuador 79
CO - Colombia 78
AE - Emirati Arabi Uniti 75
LT - Lituania 70
VE - Venezuela 54
MY - Malesia 52
CH - Svizzera 49
EG - Egitto 47
IR - Iran 45
AU - Australia 43
PH - Filippine 43
CL - Cile 42
MA - Marocco 42
JM - Giamaica 40
PY - Paraguay 37
UZ - Uzbekistan 37
CZ - Repubblica Ceca 32
IL - Israele 32
CR - Costa Rica 31
JO - Giordania 31
AT - Austria 30
TN - Tunisia 30
SA - Arabia Saudita 29
TH - Thailandia 29
DZ - Algeria 28
TT - Trinidad e Tobago 26
GR - Grecia 25
NP - Nepal 25
PT - Portogallo 24
KE - Kenya 23
TW - Taiwan 22
HN - Honduras 21
PR - Porto Rico 19
UY - Uruguay 19
AZ - Azerbaigian 17
ET - Etiopia 17
KZ - Kazakistan 17
PE - Perù 17
EU - Europa 16
BO - Bolivia 15
SN - Senegal 15
DK - Danimarca 14
DO - Repubblica Dominicana 14
KG - Kirghizistan 14
BY - Bielorussia 13
LB - Libano 13
RS - Serbia 13
AL - Albania 12
EE - Estonia 12
GT - Guatemala 12
HU - Ungheria 12
NI - Nicaragua 10
NZ - Nuova Zelanda 9
OM - Oman 9
PA - Panama 9
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
QA - Qatar 8
AM - Armenia 7
CY - Cipro 7
HR - Croazia 7
LK - Sri Lanka 7
MN - Mongolia 7
NO - Norvegia 7
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
Totale 72.086
Salva come PNG Salva come JPEG
Città #
Ashburn 4.587
Southend 3.817
Santa Clara 2.925
Singapore 2.521
Fairfield 2.351
Hong Kong 1.829
Stockholm 1.818
Chandler 1.757
Woodbridge 1.635
San Jose 1.549
Hefei 1.336
Chicago 1.334
Jacksonville 1.271
Council Bluffs 1.171
Houston 1.102
Seattle 1.003
Wilmington 995
Dearborn 955
Ann Arbor 918
Los Angeles 837
Beijing 828
Cambridge 807
Nyköping 775
London 636
Modena 543
Ho Chi Minh City 501
Seoul 431
New York 405
The Dalles 397
Salt Lake City 387
Milan 373
Izmir 359
Helsinki 355
Hanoi 340
Dallas 298
Princeton 249
Sofia 234
Eugene 220
San Diego 218
Buffalo 208
Rome 207
Lauterbourg 203
Tampa 186
São Paulo 184
Bologna 170
Moscow 168
Elk Grove Village 163
Shanghai 146
Columbus 136
Phoenix 127
Munich 126
Orem 122
Des Moines 120
Jakarta 116
Redwood City 112
Lancaster 109
Frankfurt am Main 108
Tokyo 99
Dublin 95
Bremen 94
Toronto 93
Fremont 90
Naples 89
Falls Church 88
Miami 78
Boardman 76
Brussels 74
Reggio Emilia 73
Brooklyn 71
Chennai 69
Sterling 69
Montreal 68
Florence 67
Atlanta 66
Da Nang 59
Guangzhou 59
Haiphong 59
Turin 58
Dulles 55
Warsaw 55
Johannesburg 54
Catania 53
Parma 53
Washington 53
Amsterdam 51
Denver 51
Detroit 51
Baghdad 49
Bari 46
Nanjing 45
Mexico City 44
Pittsburgh 44
Como 42
Boston 40
Kansas City 39
Norwalk 39
Kent 38
Rio de Janeiro 38
Charlotte 37
San Francisco 36
Totale 49.385
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.063
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 619
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 548
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 516
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 494
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 483
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 482
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 477
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 471
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 455
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 449
Cationic liposomes for gene transfection 436
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 436
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 436
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 434
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 433
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 433
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 431
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 425
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 424
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 418
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 418
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 415
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 411
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 409
Amphiphilic ion pairs of tobramycin with lipoamino acids 403
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 396
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 393
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 392
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 388
Nanoparticle transport across the blood brain barrier 386
Polymeric nanoparticles for the drug delivery to the central nervous system 385
Vegetable cells in Papanicolaou-stained cervical smears 384
Nanomedicine: the future for advancing medicine and neuroscience 384
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 383
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 382
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 380
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 378
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 378
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 374
Brain targeting with polymeric nanoparticles: which administration route should we take? 373
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 371
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 371
Protein corona and nanoparticles: How can we investigate on? 370
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 368
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 366
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 365
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 364
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 360
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 359
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 359
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 354
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 353
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 353
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 353
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 351
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 351
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 350
Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: Characterization and ability to bind the pEGFP-plasmid 349
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 349
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 347
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 346
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 344
Preformulative and formulative studies on inclusion complexes between cyclodextrins and ursodeoxycholic acid 343
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 342
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 342
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 341
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles 341
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 341
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 341
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 339
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 337
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 336
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 336
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 335
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. 334
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 331
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 329
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 329
Functionalization of liposomes: microscopical methods for preformulative screening 328
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 328
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 327
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 326
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 323
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 323
Colloidal systems for CNS drug delivery 321
PLA/PLGA nanoparticles for sustained release of docetaxel 320
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 319
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 318
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 317
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 316
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 315
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 313
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 312
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 308
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 302
Nanoparticles and the BBB crossing: in vivo and in vitro upcomings 296
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 296
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 294
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 294
Totale 39.021
Salva come PNG Salva come JPEG
Categoria #
all - tutte 269.688
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 269.688
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.178 0 0 0 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/202511.116 526 176 238 820 2.136 1.467 897 755 1.082 503 1.148 1.368
2025/202623.708 1.329 851 1.566 2.785 4.348 1.379 2.238 1.032 3.875 1.985 1.172 1.148
2026/20275.531 502 1.266 1.943 1.820 0 0 0 0 0 0 0 0
Totale 72.634